Gsa Capital Partners LLP Axonics, Inc. Transaction History

Gsa Capital Partners LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$56.67 - $69.36 $238,920 - $292,421	4,216 New	4,216 $290,000
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $342,360 - $429,538	7,134 Added 118.58%	13,150 $663,000
Q1 2023 May 12, 2023	SELL	$52.6 - $67.34 $787,685 - $1.01 Million	-14,975 Reduced 71.34%	6,016 $328,000
Q4 2022 Feb 13, 2023	BUY	$59.56 - $76.6 $816,567 - $1.05 Million	13,710 Added 188.3%	20,991 $1.31 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $422,006 - $568,791	7,281 New	7,281 $513,000
Q4 2020 Feb 03, 2021	SELL	$42.19 - $51.5 $362,116 - $442,024	-8,583 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$35.33 - $51.04 $303,237 - $438,076	8,583 New	8,583 $438,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.